---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-008217"
form_type: "8-K/A"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2023-03-20T23:59:59+00:00"
generated_at: "2026-06-17T22:55:24.566608+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience acquires Wisconsin Fertility Institute for $10M; clinic had $5.7M revenue in 2021

## Summary
- Total purchase price $10M, payable in four annual $2.5M installments.
- Sellers can elect to receive INVO common stock at $6.25, $9.09, $14.29 for installments 2-4.
- Clinic revenue $5.7M (2021), $4.5M (2020); net income $2.3M and $1.3M respectively.
- Acquisition includes WFRSA medical practice and FLOW lab services; expected close Q2 2023.

## SEC filing metadata
- accession: 0001493152-23-008217
- form_type: 8-K/A
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2023-03-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315223008217/0001493152-23-008217-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315223008217/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-008217
- JSON: https://secwatch.observer/filing/0001493152-23-008217.json
- Plain text: https://secwatch.observer/filing/0001493152-23-008217.txt

## Key facts
- Material Agreements
  INVO Fertility, Inc. entered into Asset Purchase Agreement with WFRSA and The Elizabeth Pritts Revocable Living Trust (effective 2023-03-16).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: WFRSA and The Elizabeth Pritts Revocable Living Trust
  - Effective: 2023-03-16
  source text: On March 16, 2023, Buyer entered into an Asset Purchase Agreement (the “APA”) with WFRSA and The Elizabeth Pritts Revocable Living Trust (the “Seller,” together with the WFRSA, the “Seller Parties”) pursuant to which Buyer agreed to acquire the Purchased Assets (as defined in the APA) related to WFRSA’s business.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223008217/0001493152-23-008217-index.htm
- Material Agreements
  INVO Fertility, Inc. entered into Membership Interest Purchase Agreement with FLOW, IVF Science, LLC, owned by Wael Megid, Ph.D., and Dr. Elizabeth Pritts as trustee for the Elizabeth Pritts Revocable List Trust (effective 2023-03-16).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: FLOW, IVF Science, LLC, owned by Wael Megid, Ph.D., and Dr. Elizabeth Pritts as trustee for the Elizabeth Pritts Revocable List Trust
  - Effective: 2023-03-16
  source text: On March 16, 2023, Buyer entered into a Membership Interest Purchase Agreement (the “MIPA”) with FLOW, IVF Science, LLC, a Wisconsin limited liability company (“IVF Science”), owned by Wael Megid, Ph.D. (“Dr. Megid”), and Dr. Elizabeth Pritts as trustee for the Elizabeth Pritts Revocable List Trust, a Trust created under the laws of the State of Wisconsin (each, a “Selling Member” and collectively, the “Selling Members”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223008217/0001493152-23-008217-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.